In 74 patients with IPF receiving antifibrotic therapy, sleep quality improved significantly, as the median Pittsburgh Sleep Quality Index score fell from 9 to 6. Patients with idiopathic pulmonary ...
Best practices most often mentioned by amyloidosis stakeholders included patient-centric multidisciplinary care, responsiveness to patients' questions, and timely intake of new patients who are at ...
Dual pathway blockade targets complement-driven pathology in AChR-positive MG, as well as FcRn-mediated pathogenic IgG recycling. Two patients with refractory anti-acetylcholine receptor (AChR) ...
After the enzyme-linked immunosorbent assay was added to the solid phase red cell adherence test, the detection rate of anti-CD36 increased about 15-fold. Platelet antibodies that may lead to fetal ...
The pathogenic role of CD38-expressing plasma cells in FSGS may be linked to the therapeutic effect, given that circulating CD38+ plasma cell counts have been shown to correlate with disease activity.
Regenxbio announced plans to pursue accelerated FDA approval of RGX-202 and prepare for a potential commercial launch in 2027. The pivotal portion of the trial of RGX-202, a gene therapy for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results